Evidence map›Paper›PMID 22432703›Full record

ReviewMicrobial drug resistance (Larchmont, N.Y.)2012

The lytic transglycosylases of Neisseria gonorrhoeae.

Yolande A Chan, Kathleen T Hackett, Joseph P Dillard

Open access · hybridAbstract readReview
In one paragraph

Review in Microbial drug resistance (Larchmont, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. The role of extracellular DNA inJournal of bacteriology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Lytic transglycosylase Slt of Pseudomonas aeruginosa as a periplasmic hub protein.Protein science : a publication of the Protein Society · 2024
    Article
  8. Mutation ofJournal of bacteriology · 2023
    Article
  9. Mutation ofbioRxiv : the preprint server for biology · 2023
    Article
  10. Review
  11. Article
  12. Anti-Virulence Therapeutic Approaches forAntibiotics (Basel, Switzerland) · 2021
    Review
  13. A NovelFrontiers in microbiology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Antibiotic Targets in Gonococcal Cell Wall Metabolism.Antibiotics (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yolande A ChanDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin 53706, USA.
Kathleen T Hackett
Joseph P Dillard
University of Wisconsin–Madison · US

Funding

Type IV Secretion by Neisseria gonorrhoeaeR01AI047958 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI DILLARD, JOSEPH P · 2002 to 2019
$5.0M
NIAID NIH HHS R01 AI047958NIAID NIH HHS R01AI047958
6 · The paper itself

Abstract

Neisseria gonorrhoeae encodes five lytic transglycosylases (LTs) in the core genome, and most gonococcal strains also carry the gonococcal genetic island that encodes one or two additional LTs. These peptidoglycan (PG)-degrading enzymes are required for a number of processes that are either involved in the normal growth of the bacteria or affect the pathogenesis and gene transfer aspects of this species that make N. gonorrhoeae highly inflammatory and highly genetically variable. Systematic mutagenesis determined that two LTs are involved in producing the 1,6-anhydro PG monomers that cause the death of ciliated cells in Fallopian tubes. Here, we review the information available on these enzymes and discuss their roles in bacterial growth, cell separation, autolysis, type IV secretion, and pathogenesis.

Indexed as

Bacterial ProteinsCiliaEpithelial CellsFallopian TubesFemaleGlycosyltransferasesGonorrheaHumansIsoenzymesMutagenesisMutationNeisseria gonorrhoeaePeptide FragmentsPeptidoglycanBacterial ProteinsGlycosyltransferasesIsoenzymesPeptide FragmentsPeptidoglycan

Identifiers

PMID22432703
PMCPMC3412582
OpenAlexW2047179112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.